Amphotericin B Powder

Amphotericin B Powder

1.Other name:amphotericin 99% B
2.Appearance:yellow powder
3.Specification:pharmaceutical grade
4.CAS:1397-89-3
5.10 years experience on natural ingredients industry.
Send Inquiry
Description
Send Inquiry

Xi'an Le-Nutra Ingredients Inc is one of the most professional manufacturers and suppliers of amphotericin b powder in China, featured by quality products and low price. Please rest assured to wholesale bulk amphotericin b powder for sale here from our factory. Customized orders are welcome.

 

Product Introduction

 

 

Amphotericin B Powder is a polyene antifungal antibiotic produced by Streptomyces nodosus. It has been the gold standard for treating invasive fungal infections and visceral leishmaniasis for over 60 years. The chemical formula is C₄₇H₇₃NO₁₇, and the molecular weight is 924.08 g/mol. CAS number 1397-89-3.

 

I'll be honest about the one issue that shapes everything in this molecule: solubility. Amphotericin B powder is practically insoluble in water and also poorly soluble in most lipid solvents. The amphiphilic and zwitterionic character of the molecule means it resists both aqueous and lipid dissolution, and its gastrointestinal permeability is negligible. This is not a footnote - it's the reason every commercial formulation on the market requires parenteral administration, and it's the first thing your formulation team will ask about when you send them a sample.

Amphotericin B

 

Why Choose Us

 

 

Our Advantage What It Means for You
GMP-certified production Our manufacturing partner holds US FDA GMP certification with an active Drug Master File (DMF) and Certificate of European Pharmacopoeia (CEP) for Amphotericin B.
USP / EP dual compliance Every batch meets both pharmacopoeia specifications. COA reports potency by microbial assay and HPLC, impurity profile, and loss on drying.
Formulation support We understand the solubility problem. Our technical team can discuss deoxycholate complexation, lipid complex preparation, and liposomal encapsulation approaches with your formulation group.
Impurity control We report Impurity A (amphotericin A) at ≤ 5.0%, Impurity B at ≤ 4.0%, and total impurities at ≤ 15.0% per Ph. Eur.. These are the numbers your regulatory team needs.
Batch traceability Full documentation chain from fermentation lot to finished drum. Retention samples held for 5 years.
Competitive China pricing As a direct manufacturer-side supplier, we cut out trading-company markup. You get CEP-grade quality at China sourcing economics.
OEM / CDMO support We can discuss custom particle size, sterile processing coordination, and finished formulation development through our CDMO partners.

 

Technical Data Sheet

 

 

Item Specification Method
Product Name Amphotericin B -
CAS Number 1397-89-3 -
EINECS 215-742-2 -
Molecular Formula C₄₇H₇₃NO₁₇ -
Molecular Weight 924.08 g/mol -
Appearance Yellow to orange crystalline powder Visual
Odour Odourless or almost odourless Organoleptic
Solubility Practically insoluble in water; soluble in DMSO -
Potency (Microbial Assay) ≥ 750 µg/mg (dried basis) USP
Potency (HPLC) ≥ 750 µg/mg (dried basis) HPLC
Identification (IR) Conforms to standard Ph. Eur.
Identification (HPLC) Conforms to standard Ph. Eur.
Impurity A (Amphotericin A) ≤ 5.0% (at 303 nm) Ph. Eur.
Impurity B ≤ 4.0% (at 383 nm) Ph. Eur.
Any Other Individual Impurity ≤ 1.0% (at 303 nm); ≤ 2.0% (at 383 nm) Ph. Eur.
Total Impurities ≤ 15.0% (at 303 nm + 383 nm) Ph. Eur.
Loss on Drying ≤ 5.0% (5 mmHg, 60°C) USP
Residue on Ignition / Sulphated Ash ≤ 0.5% (USP) / ≤ 3.0% (Ph. Eur.) USP / Ph. Eur.
Heavy Metals ≤ 20 ppm USP
Bacterial Endotoxins ≤ 0.5 EU/mg (for sterile processing grades) LAL
Microbial Limits TAMC ≤ 100 cfu/g; TYMC ≤ 10 cfu/g USP <61>
Storage +2°C to +8°C, protected from light -
Packaging 100 g / 500 g / 1 kg amber glass or aluminum foil bag -
Shelf Life 36 months (sealed, proper storage) -
Pharmacopoeia USP / Ph. Eur. -

 

Functions & Benefits

 

 

Broad-Spectrum Antifungal Activity
Amphotericin B binds irreversibly to ergosterol, the primary sterol in fungal cell membranes. This binding forms transmembrane pores that disrupt osmotic integrity, causing leakage of monovalent ions (Na⁺, K⁺), water, and glucose, leading to concentration-dependent cell death. The spectrum covers most pathogenic fungi: Aspergillus spp., Candida spp., Cryptococcus neoformans, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum, and the agents of mucormycosis.

 

Antileishmanial Activity
Amphotericin B also binds ergosterol in the membrane of Leishmania parasites, causing ion-leaking pores and subsequent cell death. This makes it a treatment of choice for visceral leishmaniasis, particularly in regions where antimonial resistance is prevalent.

 

Fungicidal Mechanism
Amphotericin B is fungicidal, not merely fungistatic. Activity is concentration-dependent with a prolonged post-antibiotic effect. Resistance is infrequent and limited to specific isolates including Candida lusitaniae, Candida glabrata, Aspergillus terreus, Scedosporium spp., and Fusarium spp..

 

Reduced Toxicity in Lipid Formulations 
When formulated as liposomal amphotericin B (LAmB), the drug is as effective as the conventional deoxycholate formulation but significantly less toxic to kidneys. This matters in clinical settings where renal function monitoring capacity is limited. The API we supply is the same starting material for all three commercial formulation types.

 

Products Applications

 

 

  • Conventional Deoxycholate Formulation

The classic formulation combines Amphotericin B with sodium deoxycholate to form micelles in aqueous solution, enabling intravenous administration of the otherwise insoluble drug. This remains the most accessible formulation in low- and middle-income countries. We supply both the API and sodium deoxycholate for manufacturers producing this formulation.

 

  • Liposomal Amphotericin B (LAmB) 

LAmB consists of a stable ionic complex with a lipid bilayer in the form of small unilamellar vesicles made from hydrogenated soy phosphatidylcholine and distearoylphosphatidylglycerol stabilized with cholesterol. Manufacturing LAmB is technically demanding - liposome size variation affects drug release and toxicity profiles. We supply the API with tight particle size control and batch-specific impurity data to support your liposome development work.

 

  • Amphotericin B Lipid Complex

Formed by combining dimyristoyl phosphatidylcholine and dimyristoyl phosphatidylglycerol with Amphotericin B, creating ribbon-like bilayer structures. This formulation offers an alternative toxicity profile for patients who cannot tolerate the deoxycholate version.

 

  • Oral Formulation Development 

This is the frontier. Amphotericin B-MAPC (monoacyl-phosphatidylcholine) complexes convert the crystalline drug to an amorphous form, improving dissolution rate and aqueous solubility. Research shows this approach could enable oral delivery, eliminating infusion-related toxicities and reducing nephrotoxicity. If your R&D team is working on oral Amphotericin B, we can supply API for formulation studies with the documentation your regulatory pathway requires.

 

  • Dermatological Preparations

Amphotericin B is used in topical creams and ointments for cutaneous fungal infections. Note that USP specifies different requirements for Amphotericin B intended for dermatological creams. Tell us your intended application and we'll match the grade.

 

Amphotericin B powder...

 

FAQ

 

 

 

 

Q1: What's the difference between Amphotericin B API and the finished injection?
The API is the raw active ingredient. The finished injection adds sodium deoxycholate and buffering substances to make the insoluble drug administrable via IV infusion. We supply the API. If you also need deoxycholate, we can quote that separately.

 

Q2: How do you address the solubility problem?
We don't - that's your formulation team's job. What we do is supply API with the particle size distribution, impurity profile, and potency data they need to develop a working formulation. For deoxycholate micelle, lipid complex, or liposomal approaches, the API starting material is the same. The formulation determines the final product characteristics.

 

Q3: What's the potency specification?
Not less than 750 µg/mg on the dried basis, by both microbial assay and HPLC. This is the USP and Ph. Eur. standard. We report both methods on the COA.

 

Q4: What impurity limits do you guarantee?
Impurity A (amphotericin A) ≤ 5.0% at 303 nm, Impurity B ≤ 4.0% at 383 nm, any other individual impurity ≤ 1.0% at 303 nm and ≤ 2.0% at 383 nm, total impurities ≤ 15.0%. These are Ph. Eur. limits, and we meet them on every batch.

 

Q5: What certifications does your manufacturing partner hold?
US FDA GMP certification with an active DMF and CEP for Amphotericin B. The most recent FDA inspection closed as VAI (Voluntary Action Indicated) in May 2024. ISO certification and EDQM CEP documentation are available for your regulatory team.

 

Q6: What's the MOQ for bulk orders?
100 g for evaluation. 1 kg for pilot batches. 5 kg+ for commercial-scale orders. For sterile processing coordination, minimum quantities are higher - discuss with your account manager.

 

Q7: Do you supply sterile Amphotericin B powder?
We supply non-sterile API. For sterile powder for injection, we can coordinate with our CDMO partners who hold sterile processing capabilities. This is a separate service with separate documentation requirements.

 

Q8: How do you ship temperature-sensitive material?
In amber glass or light-blocking aluminum foil bags, with temperature monitoring data loggers on request. We recommend +2°C to +8°C storage and can arrange cold-chain shipping for large orders. For sample quantities, insulated packaging with gel packs is standard.

 

Q9: What documents come with each batch?
COA (batch-specific, with microbial and HPLC assay, impurity profile, LOD, residue on ignition), MSDS, DMF and CEP reference numbers, elemental impurity risk assessment, and stability data summary. Additional documentation for your regulatory submission can be arranged.

 

Q10: Can you help with formulation development?
We can discuss the technical challenges - the solubility issue, the deoxycholate complexation approach, the MAPC amorphous complex pathway - but we are an API supplier, not a formulation house. For CDMO services, we can make introductions to partners who specialize in polyene formulation.

Amphotericin B powder1

 

Our Packages

 

Hydrolyzed Potato Protein Powder

Our Factory

 

 

Hydrolyzed Rice Protein

 

Our Logistics

 

 

product-1300-480

 

Our Logistics

 

 

product-820-317

 

Our Logistics

 

 

Hydrolyzed Rice Protein

 

Contact Us

 

 

To explore how our Hydrolysed Rice Peptide can enhance your products, contact us at info@lenutra.com, aimee@lenutra.com

Hot Tags: amphotericin b powder, China amphotericin b powder manufacturers, suppliers, factory, Pure Apigenin, 33 Diindolylmethane, Chitosan Oligosaccharide, Pure Indole-3-carbinol, Centella Asiatica Powder, Piperine Powder

Send Inquiry